CEBPA and acute myeloid leukemia: Note that a better clinical outcome of CEBPA mutant AML is associated with cells containing C/EBPα bZIP domain mutation, irrespective of whether it is co-expressed with a wt protein or a C-terminal mutant as in CEBPAN/C AML [11].